Site of Care Shift: Why Payers Are Moving Infusions to Clinics
Site of care has become one of the most important ideas shaping the infusion business. For years, many infused therapies were administered in hospital outpatient departments. Increasingly, commercial insurers and other payers are encouraging, and in some cases requiring, that eligible patients receive those therapies in lower-cost settings such as ambulatory infusion centers, physician office suites or the home.
For infusion center owners, founders and buyers, this shift is a key part of the growth story. It is also a factor lenders consider when reviewing projections. This article explains what site of care policies are, why payers use them and what they may mean for infusion center financing. Payer policies vary widely by plan, region and therapy, and nothing here is clinical, legal, billing or compliance advice.
What Site of Care Policies Are
A site of care policy is a payer rule or program that directs where certain services may be delivered and reimbursed. For infusions, these policies may:
- Require prior review before a hospital outpatient infusion is approved
- Redirect eligible patients to ambulatory centers, office suites or home infusion
- Offer different patient cost-sharing depending on the setting
- Exempt certain patients based on clinical factors, such as the first doses of a new therapy
Clinical decisions about where a patient should be treated belong to the patient and their physicians. Policies typically include exceptions for patients who need hospital-level monitoring.
Why Payers Are Moving Infusions to Clinics
Payers point to several reasons for these policies:
- Cost: hospital outpatient departments often bill facility charges and may be reimbursed differently than ambulatory settings
- Patient experience: standalone centers may offer easier parking, shorter waits and more comfortable surroundings
- Access: community centers can bring infusions closer to where patients live
- Capacity: moving routine infusions out of hospitals can free hospital resources for higher-acuity care
Hospitals and some patient groups have raised concerns about these policies, and how they are applied varies. Owners should follow the specific policies of the payers in their market.
What the Site of Care Shift Means for Infusion Centers
For ambulatory infusion centers, these policies can create opportunity:
- More referrals from payers and physicians seeking in-network alternatives to hospital infusion
- Stronger negotiating position with payers that want ambulatory capacity
- Demand for new centers in underserved markets
- Interest from buyers and investors in independent centers
They also bring responsibilities. Centers must have the clinical protocols, staffing and supervision to safely serve patients redirected from hospitals, and they must manage prior authorization and documentation carefully with the help of qualified billing professionals.
Risks to Keep in View
The site of care trend is not a promise of volume. Owners and lenders should consider:
- Policy changes: payers can revise policies, add exceptions or change reimbursement
- Competition: physician practices, health systems and larger infusion platforms may compete for the same patients
- Specialty pharmacy routing: some payers may require drugs to be supplied by designated pharmacies, which can change a center’s margins
- Payer concentration: a center built around one payer’s policy may be exposed if that payer changes direction
How Lenders View Site of Care Projections
When founders or buyers cite site of care trends to support projections, lenders typically want evidence that the trend applies locally. Helpful support may include:
- The specific payers in the market and their published policies
- Referral commitments from prescribing physicians
- Current infusion options in the area and their capacity
- Payer contracting status for the new or existing center
- Conservative volume assumptions that do not depend on a single policy
An infusion center business plan that ties site of care trends to local data is often more persuasive than one that relies on national headlines.
Implications for Startups and Expansion
Site of care policies have encouraged many operators to open new centers or add locations. Founders planning a new center can review the cost to open an infusion center to understand the investment involved. Established operators considering growth can read about infusion center expansion and our infusion therapy expansion financing options.
Buyers may also see site of care trends as part of the case for acquiring an existing center. Our article on how to buy an infusion center explains what to review before making an offer.
The Role of Home Infusion
Payers also steer some patients toward home infusion when it is clinically appropriate. That can benefit home infusion pharmacies, but it can also mean that some patients an ambulatory center expected to serve are treated at home instead. Owners who understand how local payers divide care between clinics and homes can build more realistic plans, and some operators choose to offer both models.
Margins Still Matter
More volume does not automatically mean more profit. Drug margins, administration revenue, staffing and collections determine whether each additional patient strengthens the center. Our article on how profitable an infusion center can be explains the drivers.
Final Thoughts
The site of care shift is reshaping where infusions happen and creating opportunities for ambulatory centers. It is also a moving target: payer policies change, competition grows and margins depend on more than volume. Owners and founders who ground their plans in local payer policies, referral relationships and conservative projections are better positioned to use the trend to support financing.
US Medical Funding helps infusion therapy owners, founders and buyers finance centers in a changing payer environment. Learn more about our full range of infusion therapy center financing options.
